Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience. Andrea M, Emanuele V, Susanna B, Francesca N, et al. J Asthma 2022 Feb 3:1-10. doi: 10.1080/02770903.2022.2036754.

Read + Share

Amedeo Smart

Independent Medical Education

Andrea M, Emanuele V, Susanna B, Francesca N, et al. Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience. J Asthma 2022 Feb 3:1-10. doi: 10.1080/02770903.2022.2036754.
PMID: 35112934